Metastatic carcinoma of the prostate presenting as a superior vena cava syndrome.
A 75-year-old patient presented with a superior vena cava syndrome (SVCS) lasting 3 years. A prostatic carcinoma was found and a supraclavicular lymph node biopsy specimen disclosed metastasis of the prostatic carcinoma. Antiandrogen and luteinizing hormone-releasing hormone analogue therapy produced a marked improvement. Prostatic carcinoma, although a very rare cause, must be considered in the diagnosis of cases of SVCS with a protracted course, since it is a treatable disease.
Montalbán
C
C
Department of Internal Medicine, Hospital Ramón y Cajal, Universidad de Alcalá, Madrid, Spain.
Moreno
M A
MA
Molina
J P
JP
Hernanz
I
I
Bellas
C
C
D000230:Adenocarcinoma / Q000150:complications / Q000188:drug therapy / Q000556:secondary*; D000368:Aged; D001706:Biopsy; D005485:Flutamide / Q000627:therapeutic use; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D008297:Male; D011471:Prostatic Neoplasms / Q000473:pathology*; D013479:Superior Vena Cava Syndrome / Q000209:etiology*; D013997:Time Factors; D017329:Triptorelin Pamoate / Q000627:therapeutic use
D017329:Triptorelin Pamoate; D005485:Flutamide